Novo Nordisk Ends Partnership with HIMS & HERS Stock Plunges

NewsNews
PostsPosts
SelectionSelection

- BarcodeBarcode
  ·2025-06-24
  $Hims & Hers Health Inc.(HIMS)$ 🚨⚖️💊HIMS vs Big Pharma: Crackdown or Correction?💊⚖️🚨 $HIMS just got smacked with a seismic downgrade. Needham has pulled it off their Conviction List and downgraded the stock to Hold, following the abrupt termination of its high-profile GLP-1 distribution deal with Novo Nordisk. The stock cratered over 30% intraday to $44.08, breaking through key Fibonacci resistance and testing the 1.272 extension. But is this the end of the bull thesis or a rare asymmetric setup in disguise? This post unpacks everything, the analyst downgrade, insider sourcing claims, technical positioning, and forward setups. 📉 Catalyst: Novo Pulls the Plug Needham’s note cited “deceptive promotion” and “illegitimate Wegovy knockoffs” as reas
  3.80K 15
  43
  Share
  Report
- BarcodeBarcode
  ·2025-06-24
  $Hims & Hers Health Inc.(HIMS)$ 🚨⚖️💊HIMS vs Big Pharma: Crackdown or Correction?💊⚖️🚨 $HIMS just got smacked with a seismic downgrade. Needham has pulled it off their Conviction List and downgraded the stock to Hold, following the abrupt termination of its high-profile GLP-1 distribution deal with Novo Nordisk. The stock cratered over 30% intraday to $44.08, breaking through key Fibonacci resistance and testing the 1.272 extension. But is this the end of the bull thesis or a rare asymmetric setup in disguise? This post unpacks everything, the analyst downgrade, insider sourcing claims, technical positioning, and forward setups. 📉 Catalyst: Novo Pulls the Plug Needham’s note cited “deceptive promotion” and “illegitimate Wegovy knockoffs” as reas
  3.80K 15
  43
  Share
  Report

To The Moon

Novo Nordisk Ends Partnership with HIMS & HERS Stock Plunges

异动解读 | Hims & Hers Health盘前反弹5.10%，投资者重新评估与诺和诺德合作终止影响

Stock Track | Hims & Hers Health Soars 5.10% Pre-Market as Investors Reassess Impact of Novo Nordisk Split

Stock Track | Hims & Hers Health Soars 5.72% After 35% Plunge Following Novo Nordisk Partnership Termination

异动解读 | Hims & Hers夜盘反弹5.72%，投资者重新评估与诺和诺德合作终止影响

Hims & Hers Health Inc. drops 0.05% after Novo Nordisk ends collaboration

美股夜盘 | Hims & Hers Health大跌0.05%，Novo Nordisk终止合作

Stock Track | Hims & Hers Health Soars 5% After Hours Following Controversial Split with Novo Nordisk

异动解读 | Hims & Hers盘后大涨5.02%，投资者消化合作终止影响

Needham Downgrades Hims & Hers Health to Hold From Buy; Shares Slide

【美股异动 | 诺和诺德(NVO.US)跌近6% 终止与Hims & Hers的合作】智通财经APP获悉，周一，诺和诺德

Hims & Hers Health Down Over 27%, on Track for Record Percent Decrease -- Data Talk

美股异动 | 诺和诺德一度跌近7%，新减肥药临床试验副作用率近80%

美股异动 | Hims & Hers Health盘初暴跌超30%，诺和诺德宣布停止与该公司合作

在诺和诺德表示Hims & Hers Health公司将不再能直接获取其减肥药后Hims & Hers Health公司

Stock Track | Hims & Hers Health Plummets Nearly 30% as Novo Nordisk Ends Weight Loss Drug Partnership

Hims & Hers Health Shares Down 29.5% After Novo Nordisk Says Co Will No Longer Have Direct Access to Its Weight Loss Drug

异动解读 | 诺和诺德终止合作，Hims & Hers Health盘中大跌近30%

开盘 | 三大指数低开，特斯拉涨超4%，英伟达跌近1%，HIMS大跌近30%

【合作关系终止！诺和诺德(NVO.US)、Hims & Hers(HIMS.US)股价双双跳水】智通财经APP获悉，诺和

Hims & Hers Health Shares Extend Losses Premarket; Last Down 20%

Novo Nordisk Terminates Collaboration With Hims & Hers Health, Inc. Due to Concerns About Their Illegal Mass Compounding and Deceptive Marketing

诺和诺德美股盘前跌幅扩大

Novo Nordisk Ends Collaboration With Hims & Hers Over Weight Loss Drug Sale

诺和诺德因减肥药销售问题终止与 Hims & Hers 的合作

Stock Track | Hims & Hers Health Plummets 18.56% Pre-market as Novo Nordisk Terminates Weight Loss Drug Access

异动解读 | Hims & Hers Health股价盘前暴跌18.56%，诺和诺德宣布终止合作

Hims & Hers Health美股盘前短线下跌现跌超18%报道称诺和诺德停止与该公司合作。

Hims & Hers Health Shares Fall 14% Premarket After Novo Nordisk Says Co Will No Longer Have Direct Access to Its Weight Loss Drug

BRIEF-Novo Nordisk Terminates Collaboration With Hims & Hers Health

异动解读 | 诺和诺德新型减肥药数据不及预期股价盘前大跌5%

异动解读 | 诺和诺德新型减肥药临床试验数据不及预期股价盘前大跌5.08%

HIMS & HERS盘前下跌7.5%此前诺和诺德宣布与该公司终止合作。

Novo Nordisk - Terminates Collaboration With Hims & Hers Health, Inc

【美股盘前】原油、黄金冲高回落；特斯拉涨超1%，Robotaxi服务于奥斯汀推出；高瓴资本据悉拟收购星巴克中国业务；新减肥药临床试验数据不佳，诺和诺德跌超3%

Novo Nordisk Ends Partnership with HIMS & HERS Stock Plunges

异动解读 | Hims & Hers Health盘前反弹5.10%，投资者重新评估与诺和诺德合作终止影响

Stock Track | Hims & Hers Health Soars 5.10% Pre-Market as Investors Reassess Impact of Novo Nordisk Split

Stock Track | Hims & Hers Health Soars 5.72% After 35% Plunge Following Novo Nordisk Partnership Termination

异动解读 | Hims & Hers夜盘反弹5.72%，投资者重新评估与诺和诺德合作终止影响

Hims & Hers Health Inc. drops 0.05% after Novo Nordisk ends collaboration

美股夜盘 | Hims & Hers Health大跌0.05%，Novo Nordisk终止合作

Stock Track | Hims & Hers Health Soars 5% After Hours Following Controversial Split with Novo Nordisk

异动解读 | Hims & Hers盘后大涨5.02%，投资者消化合作终止影响

Needham Downgrades Hims & Hers Health to Hold From Buy; Shares Slide

【美股异动 | 诺和诺德(NVO.US)跌近6% 终止与Hims & Hers的合作】智通财经APP获悉，周一，诺和诺德

Hims & Hers Health Down Over 27%, on Track for Record Percent Decrease -- Data Talk

美股异动 | 诺和诺德一度跌近7%，新减肥药临床试验副作用率近80%

美股异动 | Hims & Hers Health盘初暴跌超30%，诺和诺德宣布停止与该公司合作

在诺和诺德表示Hims & Hers Health公司将不再能直接获取其减肥药后Hims & Hers Health公司

Stock Track | Hims & Hers Health Plummets Nearly 30% as Novo Nordisk Ends Weight Loss Drug Partnership

Hims & Hers Health Shares Down 29.5% After Novo Nordisk Says Co Will No Longer Have Direct Access to Its Weight Loss Drug

异动解读 | 诺和诺德终止合作，Hims & Hers Health盘中大跌近30%

开盘 | 三大指数低开，特斯拉涨超4%，英伟达跌近1%，HIMS大跌近30%

【合作关系终止！诺和诺德(NVO.US)、Hims & Hers(HIMS.US)股价双双跳水】智通财经APP获悉，诺和

Hims & Hers Health Shares Extend Losses Premarket; Last Down 20%

Novo Nordisk Terminates Collaboration With Hims & Hers Health, Inc. Due to Concerns About Their Illegal Mass Compounding and Deceptive Marketing

诺和诺德美股盘前跌幅扩大

Novo Nordisk Ends Collaboration With Hims & Hers Over Weight Loss Drug Sale

诺和诺德因减肥药销售问题终止与 Hims & Hers 的合作

Stock Track | Hims & Hers Health Plummets 18.56% Pre-market as Novo Nordisk Terminates Weight Loss Drug Access

异动解读 | Hims & Hers Health股价盘前暴跌18.56%，诺和诺德宣布终止合作

Hims & Hers Health美股盘前短线下跌现跌超18%报道称诺和诺德停止与该公司合作。

Hims & Hers Health Shares Fall 14% Premarket After Novo Nordisk Says Co Will No Longer Have Direct Access to Its Weight Loss Drug

BRIEF-Novo Nordisk Terminates Collaboration With Hims & Hers Health

异动解读 | 诺和诺德新型减肥药数据不及预期 股价盘前大跌5%

异动解读 | 诺和诺德新型减肥药临床试验数据不及预期 股价盘前大跌5.08%

HIMS & HERS盘前下跌7.5%此前诺和诺德宣布与该公司终止合作。

Novo Nordisk - Terminates Collaboration With Hims & Hers Health, Inc

【美股盘前】原油、黄金冲高回落；特斯拉涨超1%，Robotaxi服务于奥斯汀推出；高瓴资本据悉拟收购星巴克中国业务；新减肥药临床试验数据不佳，诺和诺德跌超3%

异动解读 | 诺和诺德新型减肥药数据不及预期股价盘前大跌5%

异动解读 | 诺和诺德新型减肥药临床试验数据不及预期股价盘前大跌5.08%